Navigation Links
Lilly Reports Third-Quarter 2013 Results
Date:10/23/2013

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire/ --

  • Worldwide revenue increased 6 percent, driven by solid growth for Cymbalta, insulins, Animal Health, Alimta, Cialis and Trajenta.
  • Higher revenue and ongoing cost containment drove strong operating income growth.
  • Earnings per share totaled $1.11 for the third quarter of 2013.
  • 2013 earnings per share guidance narrowed to the range of $4.33 - $4.38 (reported), or $4.10 - $4.15 (non-GAAP).
  • Company reaffirms commitment to return cash to shareholders through its dividend and share repurchase program.
  • Eli Lilly and Company (NYSE: LLY) today announced financial results for the third quarter of 2013.$ in millions, except per share data

    Third Quarter

    %20132012

    GrowthTotal Revenue – Reported

    $5,772.6$5,443.3

    6%Net Income – Reported

    1,203.11,326.6

    (9)%EPS – Reported

     

    1.111.18

    (6)%Net Income – non-GAAP

    1,203.1888.3

    35%EPS – non-GAAP

    1.110.79

    41%Certain financial information for 2013 and 2012 is presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all revenue and expenses recognized during the period. Non-GAAP measures exclude the items described in the reconciliation tables later in the release. The non-GAAP measures are presented in order to provide additional insights into the underlying trends in the company's business. The company's 2013 financial guidance is also being provided on both a reported and a non-GAAP basis.

    "As we navigate through a period of expiring patents for some of our largest products, Lilly continues to de
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
    2. Lilly Declares Fourth-Quarter 2013 Dividend
    3. Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
    4. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
    5. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
    6. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
    7. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
    8. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
    9. Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
    10. Dr. Marschall S. Runge Elected to Lilly Board of Directors
    11. Lilly Reports Second-Quarter 2013 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/27/2015)... Varian Medical Systems UK Ltd announced today it ... and service two new national NHS proton therapy centers in ... proton therapy system. Earlier this year, Varian announced that ... NHS centers to be constructed in London ... book the equipment portion of the order in its fiscal ...
    (Date:7/27/2015)... 27, 2015   Iagnosis , the creator ... in online dermatology solutions, announced today its 2015 ... company has contractual relationships with dermatologists in 30 ... Dermatologists and Extenders Since December 2014, ... number of providers delivering care through the platform, ...
    (Date:7/27/2015)... , July 27, 2015  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, today announced ... (CTA) with Heath Canada to conduct ... d-Methadone (dextromethadone, REL-1017), its novel, N-methyl-D-aspartate (NMDA) receptor ... pain. "We are very encouraged by ...
    Breaking Medicine Technology:Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 2Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 4Iagnosis Reports Significant Growth YTD 2015 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 3
    ... 16 Trubion Pharmaceuticals, Inc. (Nasdaq: ... data regarding its SCORPION(TM) multispecific therapeutic technology at ... of Cancer Research (AACR) in Denver, April 18-22, ... data demonstrating the selectivity and high potency of ...
    ... Agonist to Advance for Treatment of AllergySAN DIEGO , ... company focused on the development of novel Toll-Like Receptor ... and inflammatory diseases, announced today that it has initiated ... intranasal TLR8 agonist for the treatment of allergic rhinitis. ...
    Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
    (Date:7/28/2015)... ... 28, 2015 , ... Peter Forbes, President of the Veterans Fund of the United States, managing ... the Veterans Coalition, is spearheading a campaign to help homeless Veterans by giving them “A ... and trade skills. Forbes and the UVBH assists and supports Vets through the Veterans ...
    (Date:7/27/2015)... ... July 28, 2015 , ... Conducting Advanced ... Techniques to Improve the Quality of Investigations , **Presented by FDAnews and Learning ... and CAPAs have been the #1 reason for 483 observations since 1997! , ...
    (Date:7/27/2015)... ... July 28, 2015 , ... The National Association of Professional Women (NAPW) ... Woman of the Year Circle. She is recognized with this prestigious distinction for leadership ... is the nation’s leading networking organization exclusively for professional women. , “I’m pleased to ...
    (Date:7/27/2015)... MA (PRWEB) , ... July 27, 2015 , ... ... has transformed the science of the little-known and incurable disease, facioscapulohumeral muscular dystrophy ... the American Academy of Neurology (AAN). The FSHD care guideline is published today. ...
    (Date:7/27/2015)... ... July 27, 2015 , ... North Central Surgical Center Hospital will be holding ... all those prospective joint-replacement patients, along with their friends and family members, to attend. ... classes (Aug 6, Sept 8 [Tue due to Labor Day], Oct 5, Nov 2, ...
    Breaking Medicine News(10 mins):Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2
    ... with advanced cancer, their muscles will gradually waste away for ... in the August 20 issue of Cell , a ... way to reverse that process in mice. What,s more, animals ... even as their tumors continued to grow. "This ...
    ... Nursing doctoral student Lisa Carter-Harris has received the Johnson ... of Colleges of Nursing Minority Nursing Faculty Scholarship for ... support to graduate nursing students from minority backgrounds who ... graduation. , The AACN will hold $1,500 to cover ...
    ... 19, 2010 Elsevier, the world,s leading publisher ... services, today announced an exclusive partnership with The ... a complete series of computed tomography modules through ... This partnership will provide technologists access to the ...
    ... from Boston University School of Medicine (BUSM) have found ... exercise in its positive effect on mood and anxiety. ... of Alternative and Complementary Medicine , is the first ... levels and decreased anxiety. The researchers set out ...
    ... receive a liver transplant due to alcoholic liver disease ... addiction treatment before transplantation. However, alcohol use disorders can ... alcohol use after liver transplantation is not uncommon. A ... of Transplantation reveals that those at highest risk ...
    ... of sex in the mainstream media has led many ... published, peer-reviewed studies have indicated that there is a ... the early onset of sexual activity among teens. However, ... these findings. Published this month in the online ...
    Cached Medicine News:Health News:With muscle-building treatment, mice live longer even as tumors grow 2Health News:With muscle-building treatment, mice live longer even as tumors grow 3Health News:UofL student wins national minority nursing scholarship 2Health News:Elsevier partners with ASRT to provide multimedia educational modules through Mosby's Imaging Suite 2Health News:Study identifies factors which predict alcohol use after liver transplantation 2Health News:For teens, early sex and media exposure not linked 2
    ... AlphaPette Pipettor is the #1 Pipettor ... accuracy, comfort, and reliability. Continuously adjustable. ... readout sub-micrometer. Easy interchangeable ejector buttons ... hands. Adjustable rapid pipet tip ejector ...
    ... Digital offers improved ergonomics for today's ... modified grippy finger rest and the ... and efficiency. Finnpipette Digitals also feature ... mechanism (pat. pend.) and super blow-out ...
    The Leader in ICU Humidification., ,Available Configurations: , Gas Sampling Port, Straight Flex Tube, Poppel Flex Tube, Luer Port for Pressure, Monitoring/Secretion Removal, Special Use Devices, M...
    ... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
    Medicine Products: